• Otol. Neurotol. · Dec 2006

    Management of lateral sinus thrombosis in chronic otitis media.

    • Mete Iseri, Omer Aydin, Emre Ustündağ, Gürkan Keskin, and Ahmet Almaç.
    • Kocaeli University Medical Faculty, Department of Otolaryngology, Izmit/Kocaeli, Turkey. metei@superonline.com
    • Otol. Neurotol. 2006 Dec 1; 27 (8): 1098-103.

    ObjectiveTo present our experience with the diagnosis and treatment of lateral sinus thrombosis (LST) secondary to otogenic disease.Patients And MethodsWe have retrospectively reviewed all the cases of LST caused by chronic otitis media in ten years.ResultsIn our series of five patients, four patients were successfully treated by surgery without opening the sigmoid sinus. On the other hand, one of our patients developed hydrocephalus and ataxia during preoperative antibiotic treatment.ConclusionMost patients with thrombotic/nonabscessed sinuses will have successful outcomes with this approach, but careful observation is needed, given the possibility of advancing disease.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.